Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2010. Start Trial.
Date Value
October 23, 2026 889.47M
October 22, 2026 907.65M
October 21, 2026 904.34M
October 20, 2026 917.56M
October 19, 2026 905.99M
October 16, 2026 896.08M
October 15, 2026 940.69M
October 14, 2026 912.60M
October 13, 2026 910.95M
October 12, 2026 939.04M
October 09, 2026 948.96M
October 08, 2026 957.22M
October 07, 2026 937.39M
October 06, 2026 917.56M
October 05, 2026 920.86M
October 02, 2026 919.21M
October 01, 2026 939.04M
September 30, 2026 973.74M
September 29, 2026 1.005B
September 28, 2026 998.53M
September 25, 2026 1.000B
September 24, 2026 1.010B
September 23, 2026 1.023B
September 22, 2026 1.065B
September 21, 2026 1.046B
Date Value
September 18, 2026 1.038B
September 17, 2026 1.017B
September 16, 2026 1.007B
September 15, 2026 988.61M
September 14, 2026 1.007B
September 11, 2026 991.92M
September 10, 2026 973.74M
September 09, 2026 990.27M
September 08, 2026 1.007B
September 04, 2026 1.022B
September 03, 2026 1.027B
September 02, 2026 1.046B
September 01, 2026 1.023B
August 31, 2026 1.020B
August 28, 2026 1.000B
August 27, 2026 1.018B
August 26, 2026 1.027B
August 25, 2026 1.043B
August 24, 2026 1.000B
August 21, 2026 1.027B
August 20, 2026 1.002B
August 19, 2026 1.038B
August 18, 2026 1.030B
August 17, 2026 1.038B
August 14, 2026 1.030B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
AbbVie, Inc. 569.05B
Xencor, Inc. 1.585B
Viking Therapeutics, Inc. 2.349B
IDEAYA Biosciences, Inc. 2.546B
BioMarin Pharmaceutical, Inc. 14.17B